Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ulrich‐Frank Pape's publication output changed over time?
ScholarIQpublication output · 2003–2023
Output grew0% over the shown period — from 1 works in 2003 to 1 in 2023.
1
1
1
1
1
1
3
1
1
1
2003200820092011201220132016201720222023
What are the most-cited papers on Ulrich‐Frank Pape?
ScholarIQmost cited works
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke, Hans‐Helge Müller, Carmen Schade‐Brittinger, Klaus‐Jochen Klose, Peter Barth, M. Wied, Christina Mayer, Behnaz Aminossadati, Ulrich‐Frank Pape, Michael Bläker, Jan Harder, Christian Arnold, Thomas M. Gress, Rudolf Arnold
Journal of Clinical Oncology. 20092,507 Citations
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
Marianne Pavel, Dermot O’Toole, Frederico Costa, Jaume Capdevila, Danae C. Gross, Réza Kianmanesh, E. P. Krenning, Ulrich Knigge, Ramón Salazar, Ulrich‐Frank Pape, Kjell Öberg, all other Vienna Consensus Conference participants
Neuroendocrinology. 20161,042 Citations
Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group
Siegbert Faiss, Ulrich‐Frank Pape, Michael Böhmig, Yvonne Dörffel, Ulrich Mansmann, W. Golder, E. O. Riecken, Bertram Wiedenmann
Journal of Clinical Oncology. 2003500 Citations
ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
Ulrich‐Frank Pape, Aurel Perren, Bruno Niederle, David J. Gross, Thomas M. Gress, Frederico Costa, Rudolf Arnold, Timm Denecke, Ursula Plöckinger, Ramón Salazar, Ashley Grossman
Neuroendocrinology. 2012463 CitationsOPEN ACCESS
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Ulrich‐Frank Pape, Henning Jann, Jacqueline Müller‐Nordhorn, Angelina Bockelbrink, Uta Berndt, Stefan N. Willich, Martin Koch, Christoph Röcken, Guido Rindi, Bertram Wiedenmann
Cancer. 2008412 CitationsOPEN ACCESS
Related on ScholarIQ
Semmelweis University
Institution
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Paper
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
Paper
Prospective, Randomized, Multicenter Trial on the Antiproliferative Effect of Lanreotide, Interferon Alfa, and Their Combination for Therapy of Metastatic Neuroendocrine Gastroenteropancreatic Tumors—The International Lanreotide and Interferon Alfa Study Group
Paper
ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas
Paper
Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors
Paper